CRISPR Therapeutics AG(CRSP)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CRSP | 4.71 B | -7.74x | 68.60% | - | $-6.17 | -31.21% | 0.43 | - | $78.48 | $44.12 |
688235.SS | 29.83 B | 111.77x | 35.50% | 8.94% | $2.32 | 12.42% | 0.43 | - | $346.00 | $205.51 |
MLTX | 1.64 B | -5.07x | - | - | $-3.88 | -77.85% | 0.40 | - | $62.75 | $5.95 |
IDIA.SW | 1.53 B | -5.82x | -2.50% | -1.01% | $-1.03 | - | - | - | $7.56 | $2.09 |
KURN.SW | 806.9 M | 341.00x | 66.90% | 1.75% | $0.06 | 3.31% | 1.65 | - | $34.20 | $17.69 |
Peer Valuation & Performance Analysis
Peer group analysis for CRISPR Therapeutics AG (CRSP) compared to its primary competitors (including 688235.SS, MLTX, IDIA.SW) reveals distinct metrics. CRSP trades at a valuation discount relative to its competitors, with a P/E ratio of -7.7x versus the peer average of 110.5x (representing a 107% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, CRSP's revenue growth of 68.6% exceeds the peer average of 33.3%, highlighting its competitive strength and market share gains.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CRSP ranks #0 in P/E ratio, #1 in revenue growth, and #3 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $47.47 | $48.62 | $47.09 | $47.78 | 1,618,000 | +0.65% |
| 2026-07-16 | $50.65 | $50.77 | $47.87 | $48.57 | 2,101,200 | -4.11% |
| 2026-07-15 | $50.46 | $51.49 | $49.92 | $51.37 | 1,309,182 | +1.80% |
| 2026-07-14 | $50.56 | $51.00 | $49.33 | $50.46 | 1,726,800 | -0.20% |
| 2026-07-13 | $52.39 | $52.96 | $50.18 | $50.63 | 1,963,000 | -3.36% |
| 2026-07-10 | $56.30 | $56.65 | $52.05 | $53.35 | 2,071,000 | -5.24% |
| 2026-07-09 | $59.24 | $60.50 | $55.88 | $56.34 | 1,434,400 | -4.90% |
| 2026-07-08 | $58.51 | $60.33 | $57.57 | $59.20 | 1,225,500 | +1.18% |
| 2026-07-07 | $62.45 | $62.80 | $58.58 | $60.77 | 1,667,200 | -2.68% |
| 2026-07-06 | $59.38 | $63.45 | $58.50 | $61.89 | 2,048,000 | +4.23% |
| 2026-07-02 | $56.18 | $61.68 | $56.18 | $60.08 | 2,931,700 | +6.94% |
| 2026-07-01 | $54.57 | $57.25 | $54.56 | $55.62 | 965,500 | +1.92% |
| 2026-06-30 | $56.35 | $56.47 | $54.45 | $54.54 | 1,186,800 | -3.21% |
| 2026-06-29 | $55.12 | $57.91 | $53.74 | $56.35 | 1,843,400 | +2.23% |
| 2026-06-26 | $53.70 | $56.15 | $53.31 | $54.92 | 3,391,300 | +2.27% |